en 35509363 <p><span style="font-size:11pt"><span style="font-size:10.0pt">More than a year has passed since the beginning of the 2019 novel coronavirus diseases (COVID-19) pandemic which has created massive problems globally affecting all aspects of people&#39;s life. Due to the emergence of new strains of the SARS-CoV-2, pandemic risk still remains, despite the start of vaccination. Therefore, rapid diagnostic tests are essential to control infection, improve clinical care and stop the spread of the disease. Recently CRISPR-based diagnostic tools have facilitated rapid diagnostic. Here, we review the diagnostic applications of CRISPR-Cas system in COVID-19.</span></span></p> COVID-19, CRISPR-Cas systems, SARS-CoV-2 3 9 https://www.ajmb.org/En/Article.aspx?id=40489 https://www.ajmb.org/PDF/En/FullText/40489.pdf HashemKhanbabaeiDepartment of Radiologic Sciences and Medical Physics, Faculty of Allied Medicine, Kerman University of Medical Sciences, Kerman, Iran71814SamanehAbbasiAbadan University of Medical Sciences, Abadan, Iran71815MonaFaniDepartment of Pathobiology and Laboratory Sciences, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Bojnurd, Iran71816SaberSoltaniDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran71817MiladZandiDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran71818ZahraNajafimemarInfectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran81817SaeedehEbrahimi71813